Clinical Trial: Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
Brief Summary: This study is to investigate the persistence of rabies Chinese manufactured antibody 1-5 years after the post-exposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose. A total of 160 subjects would be enrolled. These subjects were all administered ChengDa antirabies vaccine from 2005 to 2009. After informed consent is obtained, these subjects would be tested for their antirabies antibody titer and given a single booster dose. Seven and 14 days later, the investigators would re-evaluate the antibody titer.
Detailed Summary:
Sponsor: Peking University People's Hospital
Current Primary Outcome: Rabies antibody titer [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Peking University People's Hospital
Dates:
Date Received: July 19, 2010
Date Started: May 2010
Date Completion: September 2010
Last Updated: July 30, 2010
Last Verified: July 2010
